MedTrace Logo

Automated Detection of Brain Metastases on MRI

NCT06727032 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2025-08-03

No results posted yet for this study

Summary

This reader study aims at assessing whether the radiologist aided with AI software has at least a non-inferior performance than without AI assistance in detecting brain metastases.

200 retrospective MRI images will be included in the study with 100 positive and 100 negative exams.

Assessment will be completed by 12 readers with varying level of experience. This is a Retrospective Multiple-Reader Multiple-Case (MRMC) randomised study.

Conditions

Interventions

DEVICE

Brain Metastasis AI

There will be no intervention

Sponsors & Collaborators

  • Netherlands Cancer Institute - NKI

    collaborator UNKNOWN

  • Robovision BV

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-24
Primary Completion
2025-09-30
Completion
2025-10-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06727032 on ClinicalTrials.gov